Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Itafos Inc V.IFOS

Alternate Symbol(s):  MBCF

Itafos Inc. is a phosphate and specialty fertilizer company. Its businesses and projects include Conda, Arraias, Farim, Santana and Araxa. Conda is a vertically integrated phosphate fertilizer business located in Idaho, United States with a production capacity of over 550 Kiloton (kt) per year of mono ammonium phosphate (MAP), merchant grade phosphoric acid (MGA) and ammonium polyphosphate (APP), and approximately 27kt per year of hydrofluorosilicic acid (HFSA). Arraias is a vertically integrated phosphate fertilizer business located in Tocantins, Brazil with a production capacity of approximately 500kt per year of single superphosphate (SSP) and SSP with micronutrients (SSP+). Farim is a phosphate mine project located in Farim, Guinea-Bissau. Santana is a vertically integrated high-grade phosphate mine and fertilizer plant project located in Para, Brazil. Araxa is a vertically integrated rare earth element and niobium mine and extraction plant project located in Minas Gerais, Brazil.


TSXV:IFOS - Post by User

Post by retiredcfon Nov 25, 2021 3:56pm
245 Views
Post# 34166378

Upgrade

Upgrade

Following “another better-than-expected” quarter and a third guidance raise of the year, Raymond James analyst Steve Hansen increased his financial projections for Itafos Inc.  citing “robust/sustained phosphate price momentum, and [his] continued belief the company has a compelling path to deleveraging over the next 12-18 months.”

“Persistently tight phosphate markets and Itafos’ vastly improved earnings/FCF profile are poised to rapidly transform its historical balance sheet concerns,” he said. “This improved pathway, coupled with substantial upside optionality via the potential sale of non-core assets ($50-$100+-million), provides investors with a strong risk-reward profile, in our view.”

Maintaining an “outperform” rating, Mr. Hansen increased his target to $4, matching the consensus, from $3.75.

 

<< Previous
Bullboard Posts
Next >>